Adrenocortical carcinoma classified as benign: the limitations of washout values
- PMID: 40273001
- PMCID: PMC12056488
- DOI: 10.1530/EDM-24-0022
Adrenocortical carcinoma classified as benign: the limitations of washout values
Abstract
Summary: The new European Society of Endocrinology guidelines on the management of adrenal incidentalomas suggest discussion in a multidisciplinary meeting and consideration of additional imaging for homogenous lesions with a density >20 Hounsfield units (HU) and size <4 cm. We report a case of a 29-year-old woman who presented with benign-looking lesion on CT adrenals based on washout values, which was diagnosed as malignant on subsequent imaging. Initial hormonal work-up was normal. Two years later, the lesion had grown to 17 × 11 cm. Repeat hormonal work-up showed a raised urinary steroid profile and androstenedione along with an abnormal overnight dexamethasone suppression test. Our case report highlights a lesion being classified as benign based on washout recommendations subsequently diagnosed as adrenocortical carcinoma. We have reviewed our current clinical cohort and literature to assess the impact of the updated European guidelines on our practice, with particular reference to the use of HU.
Learning points: For the assessment of adrenal incidentalomas, CT washout values have limitations and should be interpreted with caution. Additional imaging may be required for lesions above 10 HU and this can vary according to centre expertise and availability. An adrenal lesion with a high HU value warrants follow-up imaging even if post-contrast washout values favour an adenoma. Adrenal incidentaloma are less common in younger patients, but are more likely to be clinically significant and/or malignant, so clinicians should have a lower threshold for surgery or interval imaging in indeterminate cases.
Keywords: Hounsfield Unit; adrenal adenoma; adrenal incidentaloma; adrenocortical carcinoma; washout CT.
Conflict of interest statement
The authors declare that there is no conflict of interest that could be perceived as prejudicing the impartiality of this work report.
Figures

Similar articles
-
European Society of Endocrinology clinical practice guidelines on the management of adrenal incidentalomas, in collaboration with the European Network for the Study of Adrenal Tumors.Eur J Endocrinol. 2023 Jul 20;189(1):G1-G42. doi: 10.1093/ejendo/lvad066. Eur J Endocrinol. 2023. PMID: 37318239
-
A Critical Analysis of Computed Tomography Washout in Lipid-Poor Adrenal Incidentalomas.Ann Surg Oncol. 2021 May;28(5):2756-2762. doi: 10.1245/s10434-020-09329-1. Epub 2020 Nov 18. Ann Surg Oncol. 2021. PMID: 33210268
-
Small adrenal incidentaloma becoming an aggressive adrenocortical carcinoma in a patient carrying a germline APC variant.Endocrine. 2020 Apr;68(1):203-209. doi: 10.1007/s12020-020-02209-4. Epub 2020 Feb 22. Endocrine. 2020. PMID: 32088909
-
Contemporary imaging of incidentally discovered adrenal masses.Biomed Pharmacother. 2017 Mar;87:256-262. doi: 10.1016/j.biopha.2016.12.090. Epub 2017 Jan 4. Biomed Pharmacother. 2017. PMID: 28063406 Review.
-
Discrepancies in the Recommended Management of Adrenal Incidentalomas by Various Guidelines.J Urol. 2021 Jan;205(1):52-59. doi: 10.1097/JU.0000000000001342. Epub 2020 Aug 28. J Urol. 2021. PMID: 32856984
References
-
- Fassnacht M, Tsagarakis S, Terzolo M, et al. . European Society of Endocrinology clinical practice guidelines on the management of adrenal incidentalomas, in collaboration with the European Network for the Study of Adrenal Tumors. Eur J Endocrinol 2023. 189 G1–G42. (10.1093/ejendo/lvad066) - DOI - PubMed
LinkOut - more resources
Full Text Sources